Get started
PharmaEssentia Corp. Sponsored GDR RegSPharmaEssentia Corp. Sponsored GDR RegSPharmaEssentia Corp. Sponsored GDR RegS

PharmaEssentia Corp. Sponsored GDR RegS

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Key stats


Market capitalization
‪15.70 B‬ USD
Dividend yield (indicated)
0.07%
Price to earnings Ratio (TTM)
64.4
Basic EPS (TTM)
0.6 USD
Net income (FY)
‪161.91 M‬ USD
Revenue (FY)
‪501.75 M‬ USD
Shares float
—
Beta (1Y)
0.80

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Kuo Chung Lin
Website
pharmaessentia.com
Headquarters
Taipei
Founded
2000
IPO date
Mar 11, 2014
ISIN
US7169722037
CUSIP
716972203
FIGI
BBG01G7Y1G77
Identifiers
ISIN US7169722037
PharmaEssentia Corp. engages in the research, development, production and sale of drugs. Its business activities include the manufacture and sale of therapeutic products for the treatment of human diseases. The company was founded by Kuo Chung Lin on May 9, 2000 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.